Medpace Voice

Blythe Thomson, MD, Rejoins Medpace Bringing New Experiences and Insights from a Sponsor’s Perspective

Medpace is pleased to announce that Dr. Blythe Thomson has rejoined Medpace’s Hematology and Oncology medical leadership team after spending several years holding a variety of Executive Medical Director level roles in the pharmaceutical industry.

Read More

Infectious Diseases in the Immunocompromised Host

An in-depth look at infectious diseases including hematologic malignancies in immunocompromised patients and the unique challenges for clinical development.

Read More

Medpace’s Focus on Hematology and Oncology Aligns with Innovative Biotechs

Europe is a vital contributor to a new wave of technology that is changing the face of treatments and clinical development

Read More